• 1
    Wynn TA, Thompson RW, Cheever AW & Mentink-Kane MM. Immunopathogenesis of schistosomiasis. Immunol Rev 2004; 201: 156167.
  • 2
    Fallon PG. Immunopathology of schistosomiasis: a cautionary tale of mice and men. Immunol Today 2000; 21: 2934.
  • 3
    Pearce EJ & MacDonald AS. The immunobiolgy of schistosomiasis. Nat Rev Immunol 2002; 2: 499511.
  • 4
    Byram JE & Von Lichtenberg F. Altered schistosome granuloma formation in nude mice. Am J Trop Med Hyg 1977; 26: 944956.
  • 5
    Doenhoff M, Musallam R, Bain J & McGregor A. Schistosoma mansoni infections in T-cell deprived mice, and the ameliorating effect of administering homologous chronic infection serum. I. Pathogenesis. Am J Trop Med Hyg 1979; 28: 260273.
  • 6
    Amiri P, Locksley RM, Parslow TG et al . Tumour necrosis factor α restores granulomas and induces parasite egg-laying in schistosome-infected SCID mice. Nature 1992; 3: 604607.
  • 7
    Mathew RC & Boros DL. Anti-L3T4 antibody treatment suppresses hepatic granuloma formation and abrogates antigen-induced interleukin-2 production in Schistosoma mansoni infection. Infect Immun 1986; 54: 820826.
  • 8
    Yap G, Cheever A, Caspar P, Jankovic D & Sher A. Unimpaired down-modulation of the hepatic granulomatous response in CD8 T-cell- and γ interferon-deficient mice chronically infected with Schistosoma mansoni. Infect Immun 1997; 65: 25832586.
  • 9
    Hernandez HJ, Wang Y, Tzellas N & Stadecker MJ. Expression of class II, but not class I, major histocompatibility complex molecules is required for granuloma formation in infection with Schistosoma mansoni. Eur J Immunol 1997; 27: 11701176.
  • 10
    Fallon PG, Richardson EJ, Smith P & Dunne DW. Elevated type 1, diminished type 2 cytokines and impaired antibody responses are associated with hepatotoxicity and mortalities during schistosome infection of CD4-depleted mice. Eur J Immunol 2000; 30: 470480.
  • 11
    Bluestone JA & Abbas AK. Natural versus adaptive regulatory T cells. Nat Rev Immunol 2003; 3: 253257.
  • 12
    O’Garra A & Vieira P. Regulatory T cells and mechanisms of immune system control. Nat Med 2004; 10: 801805.
  • 13
    Belkaid Y & Rouse BT. Natural regulatory T cells in infectious disease. Nat Immunol 2005; 6: 353360.
  • 14
    Hesse M, Piccirillo CA, Belkaid Y et al . The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells. J Immunol 2004; 172: 31573166.
  • 15
    Flores Villanueva PO, Chikunguwo SM, Harris TS & Stadecker MJ. Role of IL-10 on antigen-presenting cell function for schistosomal egg- specific monoclonal T helper cell responses in vitro and in vivo. J Immunol 1993; 151: 31923198.
  • 16
    Wynn TA, Cheever AW, Williams ME et al . IL-10 regulates liver pathology in acute murine Schistosomiasis mansoni but is not required for immune down-modulation of chronic disease. J Immunol 1998; 160: 44734480.
  • 17
    Hoffmann KF, Cheever AW & Wynn TA. IL-10 and the dangers of immune polarization. Excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis. J Immunol 2000; 164: 64066416.
  • 18
    Sadler CH, Rutitzky LI, Stadecker MJ & Wilson RA. IL-10 is crucial for the transition from acute to chronic disease state during infection of mice with Schistosoma mansoni. Eur J Immunol 2003; 33: 880888.
  • 19
    McKee AS & Pearce EJ. CD25+CD4+ cells contribute to Th2 polarization during helminth infection by suppressing Th1 response development. J Immunol 2004; 173: 12241231.
  • 20
    McHugh RS, Whitters MJ, Piccirillo CA et al . CD4(+) CD25(+) immunoregulatory T cells. Gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 2002; 16: 311323.
  • 21
    Hori S, Nomura T & Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299: 10571061.
  • 22
    Chikuma S & Bluestone JA. CTLA-4 and tolerance: the biochemical point of view. Immunol Res 2003; 28: 241253.
  • 23
    Tivol EA, Borriello F, Schweitzer AN, Lynch WP, Bluestone JA & Sharpe AH. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 1995; 3: 541547.
  • 24
    Waterhouse P, Penninger JM, Timms E et al . Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 1995; 270: 985988.
  • 25
    Oosterwegel MA. Mandelbrot DA, Boyd SD et al. The role of CTLA-4 in regulating Th2 differentiation. J Immunol 1999; 163: 26342639.
  • 26
    Khattri R, Auger JA, Griffin MD, Sharpe AH & Bluestone JA. Lymphoproliferative disorder in CTLA-4 knockout mice is characterized by CD28-regulated activation of Th2 responses. J Immunol 1999; 162: 57845791.
  • 27
    Mohrs M, Shinkai K, Mohrs K & Locksley RM. Analysis of type 2 immunity in vivo with a bicistronic IL-4 reporter. Immunity 2001; 15: 303311.
  • 28
    Fallon PG, Smith P & Dunne DW. Type 1 and type 2 cytokine-producing mouse CD4+ and CD8+ T cells in acute Schistosoma mansoni infection. Eur J Immunol 1998; 28: 14081416.
  • 29
    Fallon PG & Dunne DW. Tolerisation of mice to Schistosoma mansoni egg antigens causes elevated type 1 and type 2 cytokine responses and increased mortality in acute infection. J Immunol 1999; 162: 41224132.
  • 30
    Bergman L & Loxley R. Two improved and simplified methods for the spectrophotometric determination of hydroxyproline. Anal Chem 1963; 35: 19611965.
  • 31
    Kaviratne M, Hesse M, Leusink M et al . IL-13 activates a mechanism of tissue fibrosis that is completely TGF-β independent. J Immunol 2004; 173: 40204029.
  • 32
    Fallon PG, Emson CL, Smith P & McKenzie AN. IL-13 overexpression predisposes to anaphylaxis following antigen sensitization. J Immunol 2001; 166: 27122716.
  • 33
    Lowenthal JW, Corthesy P, Tougne C, Lees R, MacDonald HR & Nabholz M. High and low affinity IL 2 receptors. Analysis by IL 2 dissociation rate and reactivity with monoclonal anti-receptor antibody PC61. J Immunol 1985; 135: 39883994.
  • 34
    Saraiva M, Smith P, Fallon PG & Alcami A. Inhibition of Type 1 cytokine-mediated inflammation by a soluble CD30 homologue encoded by Ectromelia (Mousepox) virus. J Exp Med 2002; 196: 829839.
  • 35
    Mangan NE, Fallon RE, Smith P, Van Rooijen N, McKenzie AN & Fallon PG. Helminth infection protects mice from anaphylaxis via IL-10-producing B cells. J Immunol 2004; 173: 63466356.
  • 36
    Van Rijt LS, Kuipers H, Vos N, Hijdra D, Hoogsteden HC & Lambrecht BN. A rapid flow cytometric method for determining the cellular composition of bronchoalveolar lavage fluid cells in mouse models of asthma. J Immunol Methods 2004; 288: 111121.
  • 37
    Fallon PG, Ballantyne SJ, Mangan NE et al . Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion. J Exp Med 2006; 203: 11051116.
  • 38
    Mathew RC, Ragheb S & Boros DL. Recombinant IL-2 therapy reverses diminished granulomatous responsiveness in anti-L3T4-treated, Schistosoma mansoni-infected mice. J Immunol 1990; 144: 43564361.
  • 39
    Singh KP, Gerard HC, Hudson AP, Reddy TR & Boros DL. Retroviral Foxp3 gene transfer ameliorates liver granuloma pathology in Schistosoma mansoni infected mice. Immunology 2005; 114: 410417.
  • 40
    Kohm AP, McMahon JS, Podojil JR et al . Cutting Edge. Anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cells. J Immunol 2006; 176: 33013305.
  • 41
    Rosa Brunet L, Finkelman FD, Cheever AW, Kopf MA & Pearce EJ. IL-4 protects against TNF-α-mediated cachexia and death during acute schistosomiasis. J Immunol 1997; 159: 777785.
  • 42
    Fallon PG, Richardson EJ, McKenzie GJ & McKenzie AN. Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent. J Immunol 2000; 164: 25852591.
  • 43
    Lohning M, Stroehmann A, Coyle AJ et al . T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. Proc Natl Acad Sci USA 1998; 95: 69306935.
  • 44
    Khattri R, Cox T, Yasayko SA & Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 2003; 4: 3373342.
  • 45
    Fontenot JD & Rudensky AY. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat Immunol 2005; 6: 331337.
  • 46
    Baumgart M, Tompkins F, Leng J & Hesse M. Naturally occurring CD4+Foxp3+ regulatory T cells are an essential, IL-10-independent part of the immunoregulatory network in Schistosoma mansoni egg-induced inflammation. J Immunol 2006; 176: 53745387.
  • 47
    Zhang X, Reddy J, Ochi H, Frenkel D, Kuchroo VK & Weiner HL. Recovery from experimental allergic encephalomyelitis is TGF-β dependent and associated with increases in CD4+LAP+ and CD4+CD25+ T cells. Int Immunol 2006; 18: 495503.
  • 48
    Onizuka S, Tawara I, Shimizu J, Sakaguchi S, Fujita T & Nakayama E. Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor α) monoclonal antibody. Cancer Res 1999; 59: 31283133.
  • 49
    Aseffa A, Gumy A, Launois P, MacDonald HR, Louis JA & Tacchini-Cottier F. The early IL-4 response to Leishmania major and the resulting Th2 cell maturation steering progressive disease in BALB/c mice are subject to the control of regulatory CD4+CD25+ T cells. J Immunol 2002; 169: 32323241.
  • 50
    Mendez S, Reckling SK, Piccirillo CA, Sacks D & Belkaid Y. Role for CD4 (+) CD25 (+) regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity. J Exp Med 2004; 200: 201210.
  • 51
    Ko K, Yamazaki S, Nakamura K et al . Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells. J Exp Med 2005; 202: 885891.
  • 52
    Hoffmann KF, James SL, Cheever AW & Wynn TA. Studies with double cytokine-deficient mice reveal that highly polarized Th1- and Th2-type cytokine and antibody responses contribute equally to vaccine-induced immunity to Schistosoma mansoni. J Immunol 1999; 163: 927938.
  • 53
    Fallon PG, Smith P, Richardson EJ et al . Expression of interleukin-9 leads to Th2 cytokine-dominated responses and fatal enteropathy in mice with chronic Schistosoma mansoni infections. Infect Immun 2000; 68: 60056011.
  • 54
    McCoy K, Camberis M & Gros GL. Protective immunity to nematode infection is induced by CTLA-4 blockade. J Exp Med 1997; 186: 183187.
  • 55
    Castro AG, Silva RA, Minoprio P & Appelberg R. In vivo evidence for a non-T cell origin of interleukin-5. Scand J Immunol 1995; 41: 288292.
  • 56
    Rumbley CA, Sugaya H, Zekavat SA, El Refaei M, Perrin PJ & Phillips SM. Activated eosinophils are the major source of Th2-associated cytokines in the schistosome granuloma. J Immunol 1999; 162: 10031009.
  • 57
    Steel C & Nutman TB. CTLA-4 in filarial infections: implications for a role in diminished T cell reactivity. J Immunol 2003; 170: 19301938.
  • 58
    Babu S, Blauvelt CP, Kumaraswami V & Nutman TB. Regulatory networks induced by live parasites impair both Th1 and Th2 pathways in patent lymphatic filariasis: implications for parasite persistence. J Immunol 2006; 176: 32483256.
  • 59
    Hellings PW, Vandenberghe P, Kasran A et al . Blockade of CTLA-4 enhances allergic sensitization and eosinophilic airway inflammation in genetically predisposed mice. Eur J Immunol 2002; 32: 585594.
  • 60
    Van Wijk F, Hoeks S, Nierkens S et al . CTLA-4 signaling regulates the intensity of hypersensitivity responses to food antigens, but is not decisive in the induction of sensitization. J Immunol 2005; 174: 174179.
  • 61
    Alenmyr L, Matheu V, Uller L et al . Blockade of CTLA-4 promotes airway inflammation in naive mice exposed to aerosolized allergen but fails to prevent inhalation tolerance. Scand J Immunol 2005; 62: 437444.